Inari Medical, now part of Stryker, launches Artix thrombectomy system - Vascular News

Inari Medical, now part of Stryker, recently announced the launch of its Artix thrombectomy system. Purpose-built for the distinct needs of the peripheral arterial system, Artix is a combined aspiration plus mechanical thrombectomy solution that delivers procedural control and versatility, and is designed to set a new standard for arterial thrombectomy.

Stryker notes that the Artix system builds on the success of Inari’s venous thrombectomy devices and is its inaugural entry into the arterial space. “Inari offers a comprehensive toolkit approach to arterial thrombectomy with an innovative, over-the-wire system that provides physicians with the flexibility to aspirate and/or mechanically extract a clot,” a press release reads.

Jonathan Bowman (Norwalk Hospital, Norwalk, USA) performed the first commercial case with Artix on 19 October 2024. “The Artix thrombectomy system marks a significant advancement in peripheral arterial thromboembolism treatment,” said Bowman. “With Artix, I finally have a solution that effectively addresses a wide range of clots while enabling me to maintain vessel access and retain control throughout the entire case. I expect Artix will take the place of open surgical repair in many of my arterial cases.”

Key distinctive features of the Artix system include:

“There is a real clinical need to address chronic thrombi and decrease the risk of clot migration. Artix will raise the bar of effective arterial thrombectomy,” said Tom Tu, chief medical officer of Inari Medical. “We are excited to bring Inari’s core competency in thrombectomy to the arterial space with the goal of improving outcomes.”